Google partners with Broad Institute on genome analysis
Genome analysis software developed by the Broad Institute is now available in cloud form to users of Google's online genetic data storage services...
Dr Paul Waldron
Dr Paul Waldron was a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. He is currently working as a European and UK Patent Attorney at Elkington and Fife LLP in London, specialising in Life Sciences. He works with a range of clients active in the fields of industrial biotechnology and medical devices, as well as pharmaceutical areas including antibodies, nucleic acid vaccines, and cellular therapies. Previously, he worked as a Trainee Patent Attorney in the Chemistry and Life Sciences group at Keltie LLP in London. Before this he studied for a PhD at University College London's Institute of Ophthalmology, where his research focused on developing therapies for restoring vision in retinal diseases, by transplanting new light-sensitive cone cells into mouse retinas. Previously, he studied Natural Sciences at Emmanuel College at the University of Cambridge, where he specialised in Cognitive Neuroscience.
BioNews Articles by Dr Paul Waldron
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
Cancer patient appeals gene patenting decision
Australia's highest court will decide whether isolated molecules of DNA linked to a gene mutation associated with an increased risk of hereditary breast and ovarian cancers are patentable under Australian law....
Bronze Age genomics reveals origins of modern Europeans and Asians
The modern European and Central Asian gene pools are the result of mass migrations during the Bronze Age, according to a new analysis of ancient human remains...
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
Genetics study helps explain causes of schizophrenia
New research into schizophrenia has identified genetic mutations in patients which affect the balance between chemical signalling systems in the brain...
New pain sensitivity gene identified
Scientists studying people who are unable to feel pain have found a gene responsible for this rare condition...